Synthesis and evaluation of anticancer properties of novel benzimidazole ligand and their cobalt(II) and zinc(II) complexes against cancer cell lines A-2780 and DU-145
dc.authorid | Yılmaz, Ülkü/0000-0002-2806-4781 | |
dc.authorid | Tekin, Suat/0000-0002-2757-1802 | |
dc.authorid | KUCUKBAY, HASAN/0000-0002-7180-9486 | |
dc.authorid | Sandal, Suleyman/0000-0002-8916-3329 | |
dc.authorid | Bugday, Nesrin/0000-0002-3882-035X | |
dc.authorwosid | Tekin, Suat/IZD-9868-2023 | |
dc.authorwosid | Yılmaz, Ülkü/AAA-7545-2020 | |
dc.authorwosid | Tekin, Suat/AAG-1440-2021 | |
dc.authorwosid | Tekin, Suat/KEI-2266-2024 | |
dc.authorwosid | KUCUKBAY, HASAN/A-5050-2019 | |
dc.authorwosid | Sandal, Suleyman/AAA-6388-2021 | |
dc.contributor.author | Yilmaz, Ulku | |
dc.contributor.author | Tekin, Suat | |
dc.contributor.author | Bugday, Nesrin | |
dc.contributor.author | Yavuz, Kemal | |
dc.contributor.author | Kucukbay, Hasan | |
dc.contributor.author | Sandal, Suleyman | |
dc.date.accessioned | 2024-08-04T20:46:01Z | |
dc.date.available | 2024-08-04T20:46:01Z | |
dc.date.issued | 2019 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Eighteen new cobalt(II) or zinc(II) complexes of benzimidazole bearing 1-benzyl and 2-phenyl moieties were synthesized from the reaction of appropriate benzimidazole ligands and CoCl2 or ZnCl2. Their structural characterizations were done by IR, NMR (H-1, C-13) and UV-VIS spectrometers. Cytotoxic activities of eighteen new complexes and three benzimidazole ligands were determined using A-2780 (human ovarian) and DU-145 (human prostate) cell lines. Antitumor properties of all compounds were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell viability assay for the tested benzimidazole derivatives was performed and the LogIC(50) values of the compounds were calculated after a 24-hour treatment. All tested benzimidazole derivatives showed higher or comparable antitumor activity against A-2780 cell lines compared to the standard drug docetaxel with a LogIC(50) value of -0.81 mu M (p < 0.05). Eight of the examined compounds (1, 3, 5, 6, 7, 9, 10 and 13) showed high cytotoxic activity against A-2780 compared to the standard drug docetaxel. While the LogIC(50) of the docetaxel was -0.81 mu M for A-2780 cells at 24 h, the IC50 values of compounds 1, 3, 5, 6, 7, 9, 10 and 13 were - 0.97, -1.30, - 0.22, 0.13, - 0.16, - 0.73 and - 0.53 mu M, respectively. Three of the compounds 1, 18 and V showed high cytotoxic activity against DU-145 compared to docetaxel (p < 0.05). While the LogIC(50) of the docetaxel was -1.13 mu M for DU-145 cells at 24 h, the LogIC(50) values of compounds 1, 18 and V were 0.84, -0.38 and -0.66 mu M, respectively. | en_US |
dc.description.sponsorship | Inonu University, Turkey [2014/33] | en_US |
dc.description.sponsorship | We thank Inonu University, Turkey (BAPB-Grand No: 2014/33) for financial support. | en_US |
dc.identifier.doi | 10.1016/j.ica.2019.118977 | |
dc.identifier.issn | 0020-1693 | |
dc.identifier.issn | 1873-3255 | |
dc.identifier.scopus | 2-s2.0-85067980264 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.ica.2019.118977 | |
dc.identifier.uri | https://hdl.handle.net/11616/98844 | |
dc.identifier.volume | 495 | en_US |
dc.identifier.wos | WOS:000481728800045 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Sa | en_US |
dc.relation.ispartof | Inorganica Chimica Acta | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Benzimidazole complexes | en_US |
dc.subject | Cytotoxic | en_US |
dc.subject | A-2780 cell lines | en_US |
dc.subject | DU-145 cell lines | en_US |
dc.title | Synthesis and evaluation of anticancer properties of novel benzimidazole ligand and their cobalt(II) and zinc(II) complexes against cancer cell lines A-2780 and DU-145 | en_US |
dc.type | Article | en_US |